P2.01-02 Osimertinib for EGFR-Positive Advanced NSCLC with Brain Metastases: Preliminary Analysis of an Open-Label, Two-Arm, Phase 2 Study

Autor:	L. Roisman, Shlomit Yust-Katz, N. Peled, Elizabeth Dudnik, E. Inbar, L. Chen, Ofer Rotem, Anna Belilovski Rozenblum, Alona Zer, Hovav Nechushtan, Ilan Shelef
Rok vydání:	2018
Předmět:	Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty business.industry Internal medicine medicine Phases of clinical research Osimertinib Open label business Preliminary analysis
Zdroj:	Journal of Thoracic Oncology. 13:S665-S666
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2018.08.1056
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b982028e74bfbb190fd2f374755ddc84 https://doi.org/10.1016/j.jtho.2018.08.1056 Zobrazit plný text záznamu